| Symbol |
Name |
|
A1BG
|
alpha-1-B glycoprotein
|
|
ACAN
|
aggrecan
|
|
ADAMTSL1
|
ADAMTS-like 1
|
|
ADAMTSL3
|
ADAMTS-like 3
|
|
ADGRA2
|
adhesion G protein-coupled receptor A2
|
|
ADGRA3
|
adhesion G protein-coupled receptor A3
|
|
ADGRF5
|
adhesion G protein-coupled receptor F5
|
|
ADORA3
|
adenosine A3 receptor
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALPK2
|
alpha-kinase 2
|
|
ALPK3
|
alpha-kinase 3
|
|
AMICA1
|
adhesion molecule, interacts with CXADR antigen 1
|
|
AMIGO1
|
adhesion molecule with Ig-like domain 1
|
|
AMIGO2
|
adhesion molecule with Ig-like domain 2
|
|
AMIGO3
|
adhesion molecule with Ig-like domain 3
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding
|
|
B2M
|
beta-2-microglobulin
|
|
BCAM
|
basal cell adhesion molecule (Lutheran blood group)
|
|
BCAN
|
brevican
|
|
BOC
|
BOC cell adhesion associated, oncogene regulated
|
|
BSG
|
basigin (Ok blood group)
|
|
BTLA
|
B and T lymphocyte associated
|
|
BTN1A1
|
butyrophilin, subfamily 1, member A1
|
|
BTN2A1
|
butyrophilin, subfamily 2, member A1
|
|
BTN2A2
|
butyrophilin, subfamily 2, member A2
|
|
BTN3A1
|
butyrophilin, subfamily 3, member A1
|
|
BTN3A2
|
butyrophilin, subfamily 3, member A2
|
|
BTN3A3
|
butyrophilin, subfamily 3, member A3
|
|
BTNL10
|
butyrophilin-like 10
|
|
BTNL2
|
butyrophilin-like 2
|
|
BTNL3
|
butyrophilin-like 3
|
|
BTNL8
|
butyrophilin-like 8
|
|
BTNL9
|
butyrophilin-like 9
|
|
C10ORF54
|
chromosome 10 open reading frame 54
|
|
CADM1
|
cell adhesion molecule 1
|
|
CADM2
|
cell adhesion molecule 2
|
|
CADM3
|
cell adhesion molecule 3
|
|
CADM4
|
cell adhesion molecule 4
|
|
CCDC141
|
coiled-coil domain containing 141
|
|
CD101
|
CD101 molecule
|
|
CD160
|
CD160 molecule
|
|
CD19
|
CD19 molecule
|
|
CD1A
|
CD1a molecule
|
|
CD1B
|
CD1b molecule
|
|
CD1C
|
CD1c molecule
|
|
CD1D
|
CD1d molecule
|
|
CD1E
|
CD1e molecule
|
|
CD2
|
CD2 molecule
|
|
CD200
|
CD200 molecule
|
|
CD200R1
|
CD200 receptor 1
|
|
CD200R1L
|
CD200 receptor 1-like
|
|
CD22
|
CD22 molecule
|
|
CD226
|
CD226 molecule
|
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
|
CD274
|
CD274 molecule
|
|
CD276
|
CD276 molecule
|
|
CD28
|
CD28 molecule
|
|
CD300A
|
CD300a molecule
|
|
CD300C
|
CD300c molecule
|
|
CD300E
|
CD300e molecule
|
|
CD300LB
|
CD300 molecule-like family member b
|
|
CD300LD
|
CD300 molecule-like family member d
|
|
CD300LF
|
CD300 molecule-like family member f
|
|
CD300LG
|
CD300 molecule-like family member g
|
|
CD33
|
CD33 molecule
|
|
CD4
|
CD4 molecule
|
|
CD47
|
CD47 molecule
|
|
CD48
|
CD48 molecule
|
|
CD7
|
CD7 molecule
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta
|
|
CD80
|
CD80 molecule
|
|
CD83
|
CD83 molecule
|
|
CD84
|
CD84 molecule
|
|
CD86
|
CD86 molecule
|
|
CD8A
|
CD8a molecule
|
|
CD8B
|
CD8b molecule
|
|
CD96
|
CD96 molecule
|
|
CDON
|
cell adhesion associated, oncogene regulated
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM16
|
carcinoembryonic antigen-related cell adhesion molecule 16
|
|
CEACAM18
|
carcinoembryonic antigen-related cell adhesion molecule 18
|
|
CEACAM19
|
carcinoembryonic antigen-related cell adhesion molecule 19
|
|
CEACAM20
|
carcinoembryonic antigen-related cell adhesion molecule 20
|
|
CEACAM21
|
carcinoembryonic antigen-related cell adhesion molecule 21
|
|
CEACAM3
|
carcinoembryonic antigen-related cell adhesion molecule 3
|
|
CEACAM4
|
carcinoembryonic antigen-related cell adhesion molecule 4
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CEACAM7
|
carcinoembryonic antigen-related cell adhesion molecule 7
|
|
CEACAM8
|
carcinoembryonic antigen-related cell adhesion molecule 8
|
|
CHL1
|
cell adhesion molecule L1-like
|
|
CILP
|
cartilage intermediate layer protein, nucleotide pyrophosphohydrolase
|
|
CILP2
|
cartilage intermediate layer protein 2
|
|
CLMP
|
CXADR-like membrane protein
|
|
CNTFR
|
ciliary neurotrophic factor receptor
|
|
CNTN1
|
contactin 1
|
|
CNTN2
|
contactin 2 (axonal)
|
|
CNTN3
|
contactin 3 (plasmacytoma associated)
|
|
CNTN4
|
contactin 4
|
|
CNTN5
|
contactin 5
|
|
CNTN6
|
contactin 6
|
|
CRTAM
|
cytotoxic and regulatory T cell molecule
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
DCC
|
DCC netrin 1 receptor
|
|
DSCAM
|
Down syndrome cell adhesion molecule
|
|
DSCAML1
|
Down syndrome cell adhesion molecule like 1
|
|
EMB
|
embigin
|
|
ERMAP
|
erythroblast membrane-associated protein (Scianna blood group)
|
|
ESAM
|
endothelial cell adhesion molecule
|
|
F11R
|
F11 receptor
|
|
FAM187A
|
family with sequence similarity 187, member A
|
|
FCAMR
|
Fc receptor, IgA, IgM, high affinity
|
|
FCAR
|
Fc fragment of IgA receptor
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
|
FCGR1B
|
Fc fragment of IgG, high affinity Ib, receptor (CD64)
|
|
FCGR1C
|
Fc fragment of IgG, high affinity Ic, receptor (CD64), pseudogene
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
FCMR
|
Fc fragment of IgM receptor
|
|
FCRL1
|
Fc receptor-like 1
|
|
FCRL2
|
Fc receptor-like 2
|
|
FCRL3
|
Fc receptor-like 3
|
|
FCRL4
|
Fc receptor-like 4
|
|
FCRL5
|
Fc receptor-like 5
|
|
FCRL6
|
Fc receptor-like 6
|
|
FCRLA
|
Fc receptor-like A
|
|
FCRLB
|
Fc receptor-like B
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FGFRL1
|
fibroblast growth factor receptor-like 1
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FSTL4
|
follistatin-like 4
|
|
FSTL5
|
follistatin-like 5
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GPA33
|
glycoprotein A33 (transmembrane)
|
|
HAPLN1
|
hyaluronan and proteoglycan link protein 1
|
|
HAPLN2
|
hyaluronan and proteoglycan link protein 2
|
|
HAPLN3
|
hyaluronan and proteoglycan link protein 3
|
|
HAPLN4
|
hyaluronan and proteoglycan link protein 4
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HEPACAM
|
hepatic and glial cell adhesion molecule
|
|
HEPACAM2
|
HEPACAM family member 2
|
|
HFE
|
hemochromatosis
|
|
HHLA2
|
HERV-H LTR-associating 2
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DMA
|
major histocompatibility complex, class II, DM alpha
|
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta
|
|
HLA-DOA
|
major histocompatibility complex, class II, DO alpha
|
|
HLA-DOB
|
major histocompatibility complex, class II, DO beta
|
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2
|
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB3
|
major histocompatibility complex, class II, DR beta 3
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HLA-DRB5
|
major histocompatibility complex, class II, DR beta 5
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-F
|
major histocompatibility complex, class I, F
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMCN1
|
hemicentin 1
|
|
HMCN2
|
hemicentin 2
|
|
HSPG2
|
heparan sulfate proteoglycan 2
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICAM2
|
intercellular adhesion molecule 2
|
|
ICAM3
|
intercellular adhesion molecule 3
|
|
ICAM4
|
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)
|
|
ICAM5
|
intercellular adhesion molecule 5, telencephalin
|
|
ICOSLG
|
inducible T-cell co-stimulator ligand
|
|
IGDCC3
|
immunoglobulin superfamily, DCC subclass, member 3
|
|
IGDCC4
|
immunoglobulin superfamily, DCC subclass, member 4
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IGFBPL1
|
insulin-like growth factor binding protein-like 1
|
|
IGFN1
|
immunoglobulin-like and fibronectin type III domain containing 1
|
|
IGLL1
|
immunoglobulin lambda-like polypeptide 1
|
|
IGLL5
|
immunoglobulin lambda-like polypeptide 5
|
|
IGLON5
|
IgLON family member 5
|
|
IGSF1
|
immunoglobulin superfamily, member 1
|
|
IGSF10
|
immunoglobulin superfamily, member 10
|
|
IGSF11
|
immunoglobulin superfamily, member 11
|
|
IGSF21
|
immunoglobin superfamily, member 21
|
|
IGSF22
|
immunoglobulin superfamily, member 22
|
|
IGSF23
|
immunoglobulin superfamily, member 23
|
|
IGSF3
|
immunoglobulin superfamily, member 3
|
|
IGSF5
|
immunoglobulin superfamily, member 5
|
|
IGSF6
|
immunoglobulin superfamily, member 6
|
|
IGSF8
|
immunoglobulin superfamily, member 8
|
|
IGSF9
|
immunoglobulin superfamily, member 9
|
|
IGSF9B
|
immunoglobulin superfamily, member 9B
|
|
IL11RA
|
interleukin 11 receptor, alpha
|
|
IL12B
|
interleukin 12B
|
|
IL18BP
|
interleukin 18 binding protein
|
|
IL18R1
|
interleukin 18 receptor 1
|
|
IL18RAP
|
interleukin 18 receptor accessory protein
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL1R2
|
interleukin 1 receptor, type II
|
|
IL1RAP
|
interleukin 1 receptor accessory protein
|
|
IL1RAPL1
|
interleukin 1 receptor accessory protein-like 1
|
|
IL1RAPL2
|
interleukin 1 receptor accessory protein-like 2
|
|
IL1RL1
|
interleukin 1 receptor-like 1
|
|
IL1RL2
|
interleukin 1 receptor-like 2
|
|
IL6R
|
interleukin 6 receptor
|
|
ISLR
|
immunoglobulin superfamily containing leucine-rich repeat
|
|
ISLR2
|
immunoglobulin superfamily containing leucine-rich repeat 2
|
|
JAM2
|
junctional adhesion molecule 2
|
|
JAM3
|
junctional adhesion molecule 3
|
|
KALRN
|
kalirin, RhoGEF kinase
|
|
KAZALD1
|
Kazal-type serine peptidase inhibitor domain 1
|
|
KDR
|
kinase insert domain receptor
|
|
KIR2DL1
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KIR2DL3
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
|
|
KIR2DL4
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
|
|
KIR2DL5A
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A
|
|
KIR2DL5B
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5B
|
|
KIR2DS1
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
|
KIR2DS3
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3
|
|
KIR2DS4
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4
|
|
KIR2DS5
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KIR3DL2
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
|
|
KIR3DL3
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3
|
|
KIR3DP1
|
killer cell immunoglobulin-like receptor, three domains, pseudogene 1
|
|
KIR3DS1
|
killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1
|
|
KIR3DX1
|
killer cell immunoglobulin-like receptor, three domains, X1
|
|
KIRREL
|
kin of IRRE like (Drosophila)
|
|
KIRREL2
|
kin of IRRE like 2 (Drosophila)
|
|
KIRREL3
|
kin of IRRE like 3 (Drosophila)
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LAG3
|
lymphocyte-activation gene 3
|
|
LAIR1
|
leukocyte-associated immunoglobulin-like receptor 1
|
|
LAIR2
|
leukocyte-associated immunoglobulin-like receptor 2
|
|
LEPR
|
leptin receptor
|
|
LILRA1
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1
|
|
LILRA2
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2
|
|
LILRA3
|
leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3
|
|
LILRA4
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4
|
|
LILRA5
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5
|
|
LILRA6
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
|
|
LILRB3
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3
|
|
LILRB4
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4
|
|
LILRB5
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5
|
|
LINGO1
|
leucine rich repeat and Ig domain containing 1
|
|
LINGO2
|
leucine rich repeat and Ig domain containing 2
|
|
LINGO3
|
leucine rich repeat and Ig domain containing 3
|
|
LINGO4
|
leucine rich repeat and Ig domain containing 4
|
|
LRFN1
|
leucine rich repeat and fibronectin type III domain containing 1
|
|
LRFN2
|
leucine rich repeat and fibronectin type III domain containing 2
|
|
LRFN3
|
leucine rich repeat and fibronectin type III domain containing 3
|
|
LRFN4
|
leucine rich repeat and fibronectin type III domain containing 4
|
|
LRFN5
|
leucine rich repeat and fibronectin type III domain containing 5
|
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1
|
|
LRIG2
|
leucine-rich repeats and immunoglobulin-like domains 2
|
|
LRIG3
|
leucine-rich repeats and immunoglobulin-like domains 3
|
|
LRIT1
|
leucine-rich repeat, immunoglobulin-like and transmembrane domains 1
|
|
LRIT2
|
leucine-rich repeat, immunoglobulin-like and transmembrane domains 2
|
|
LRIT3
|
leucine-rich repeat, immunoglobulin-like and transmembrane domains 3
|
|
LRRC24
|
leucine rich repeat containing 24
|
|
LRRC4
|
leucine rich repeat containing 4
|
|
LRRC4B
|
leucine rich repeat containing 4B
|
|
LRRC4C
|
leucine rich repeat containing 4C
|
|
LRRN1
|
leucine rich repeat neuronal 1
|
|
LRRN2
|
leucine rich repeat neuronal 2
|
|
LRRN3
|
leucine rich repeat neuronal 3
|
|
LSAMP
|
limbic system-associated membrane protein
|
|
LSR
|
lipolysis stimulated lipoprotein receptor
|
|
LY6G6F
|
lymphocyte antigen 6 complex, locus G6F
|
|
LY9
|
lymphocyte antigen 9
|
|
MADCAM1
|
mucosal vascular addressin cell adhesion molecule 1
|
|
MAG
|
myelin associated glycoprotein
|
|
MALT1
|
MALT1 paracaspase
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MDGA1
|
MAM domain containing glycosylphosphatidylinositol anchor 1
|
|
MDGA2
|
MAM domain containing glycosylphosphatidylinositol anchor 2
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MFAP3
|
microfibrillar-associated protein 3
|
|
MFAP3L
|
microfibrillar-associated protein 3-like
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MILR1
|
mast cell immunoglobulin-like receptor 1
|
|
MMP23A
|
matrix metallopeptidase 23A (pseudogene)
|
|
MMP23B
|
matrix metallopeptidase 23B
|
|
MOG
|
myelin oligodendrocyte glycoprotein
|
|
MPZ
|
myelin protein zero
|
|
MPZL1
|
myelin protein zero-like 1
|
|
MPZL2
|
myelin protein zero-like 2
|
|
MPZL3
|
myelin protein zero-like 3
|
|
MR1
|
major histocompatibility complex, class I-related
|
|
MUSK
|
muscle, skeletal, receptor tyrosine kinase
|
|
MXRA5
|
matrix-remodelling associated 5
|
|
MXRA8
|
matrix-remodelling associated 8
|
|
MYBPC1
|
myosin binding protein C, slow type
|
|
MYBPC2
|
myosin binding protein C, fast type
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYBPH
|
myosin binding protein H
|
|
MYBPHL
|
myosin binding protein H-like
|
|
MYLK
|
myosin light chain kinase
|
|
MYOM1
|
myomesin 1
|
|
MYOM2
|
myomesin 2
|
|
MYOM3
|
myomesin 3
|
|
MYOT
|
myotilin
|
|
MYPN
|
myopalladin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCAM2
|
neural cell adhesion molecule 2
|
|
NCAN
|
neurocan
|
|
NCR1
|
natural cytotoxicity triggering receptor 1
|
|
NCR2
|
natural cytotoxicity triggering receptor 2
|
|
NCR3
|
natural cytotoxicity triggering receptor 3
|
|
NCR3LG1
|
natural killer cell cytotoxicity receptor 3 ligand 1
|
|
NEGR1
|
neuronal growth regulator 1
|
|
NEO1
|
neogenin 1
|
|
NEXN
|
nexilin (F actin binding protein)
|
|
NFASC
|
neurofascin
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPTN
|
neuroplastin
|
|
NRCAM
|
neuronal cell adhesion molecule
|
|
NRG1
|
neuregulin 1
|
|
NRG2
|
neuregulin 2
|
|
NTM
|
neurotrimin
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
OBSCN
|
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF
|
|
OBSL1
|
obscurin-like 1
|
|
OPCML
|
opioid binding protein/cell adhesion molecule-like
|
|
OSCAR
|
osteoclast associated, immunoglobulin-like receptor
|
|
PALLD
|
palladin, cytoskeletal associated protein
|
|
PAPLN
|
papilin, proteoglycan-like sulfated glycoprotein
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDGFRL
|
platelet-derived growth factor receptor-like
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PIGR
|
polymeric immunoglobulin receptor
|
|
PILRA
|
paired immunoglobin-like type 2 receptor alpha
|
|
PILRB
|
paired immunoglobin-like type 2 receptor beta
|
|
PRTG
|
protogenin
|
|
PSG1
|
pregnancy specific beta-1-glycoprotein 1
|
|
PSG11
|
pregnancy specific beta-1-glycoprotein 11
|
|
PSG2
|
pregnancy specific beta-1-glycoprotein 2
|
|
PSG3
|
pregnancy specific beta-1-glycoprotein 3
|
|
PSG4
|
pregnancy specific beta-1-glycoprotein 4
|
|
PSG5
|
pregnancy specific beta-1-glycoprotein 5
|
|
PSG6
|
pregnancy specific beta-1-glycoprotein 6
|
|
PSG7
|
pregnancy specific beta-1-glycoprotein 7 (gene/pseudogene)
|
|
PSG8
|
pregnancy specific beta-1-glycoprotein 8
|
|
PSG9
|
pregnancy specific beta-1-glycoprotein 9
|
|
PTGFRN
|
prostaglandin F2 receptor inhibitor
|
|
PTK7
|
protein tyrosine kinase 7 (inactive)
|
|
PTPRD
|
protein tyrosine phosphatase, receptor type, D
|
|
PTPRF
|
protein tyrosine phosphatase, receptor type, F
|
|
PTPRK
|
protein tyrosine phosphatase, receptor type, K
|
|
PTPRM
|
protein tyrosine phosphatase, receptor type, M
|
|
PTPRS
|
protein tyrosine phosphatase, receptor type, S
|
|
PTPRT
|
protein tyrosine phosphatase, receptor type, T
|
|
PVR
|
poliovirus receptor
|
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C)
|
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
|
PVRL3
|
poliovirus receptor-related 3
|
|
PVRL4
|
poliovirus receptor-related 4
|
|
PXDN
|
peroxidasin
|
|
PXDNL
|
peroxidasin-like
|
|
ROBO1
|
roundabout, axon guidance receptor, homolog 1 (Drosophila)
|
|
ROBO2
|
roundabout, axon guidance receptor, homolog 2 (Drosophila)
|
|
ROBO3
|
roundabout, axon guidance receptor, homolog 3 (Drosophila)
|
|
ROBO4
|
roundabout, axon guidance receptor, homolog 4 (Drosophila)
|
|
ROR1
|
receptor tyrosine kinase-like orphan receptor 1
|
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2
|
|
SCN1B
|
sodium channel, voltage gated, type I beta subunit
|
|
SCN2B
|
sodium channel, voltage gated, type II beta subunit
|
|
SCN3B
|
sodium channel, voltage gated, type III beta subunit
|
|
SCN4B
|
sodium channel, voltage gated, type IV beta subunit
|
|
SDK1
|
sidekick cell adhesion molecule 1
|
|
SDK2
|
sidekick cell adhesion molecule 2
|
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
|
SEMA3B
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B
|
|
SEMA3C
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C
|
|
SEMA3D
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D
|
|
SEMA3E
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E
|
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F
|
|
SEMA3G
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G
|
|
SEMA4C
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C
|
|
SEMA4D
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
|
|
SEMA4G
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G
|
|
SEMA7A
|
semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group)
|
|
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain
|
|
SIGLEC1
|
sialic acid binding Ig-like lectin 1, sialoadhesin
|
|
SIGLEC10
|
sialic acid binding Ig-like lectin 10
|
|
SIGLEC11
|
sialic acid binding Ig-like lectin 11
|
|
SIGLEC12
|
sialic acid binding Ig-like lectin 12 (gene/pseudogene)
|
|
SIGLEC14
|
sialic acid binding Ig-like lectin 14
|
|
SIGLEC15
|
sialic acid binding Ig-like lectin 15
|
|
SIGLEC16
|
sialic acid binding Ig-like lectin 16 (gene/pseudogene)
|
|
SIGLEC5
|
sialic acid binding Ig-like lectin 5
|
|
SIGLEC6
|
sialic acid binding Ig-like lectin 6
|
|
SIGLEC7
|
sialic acid binding Ig-like lectin 7
|
|
SIGLEC8
|
sialic acid binding Ig-like lectin 8
|
|
SIGLEC9
|
sialic acid binding Ig-like lectin 9
|
|
SIRPA
|
signal-regulatory protein alpha
|
|
SIRPB1
|
signal-regulatory protein beta 1
|
|
SIRPB2
|
signal-regulatory protein beta 2
|
|
SIRPD
|
signal-regulatory protein delta
|
|
SIRPG
|
signal-regulatory protein gamma
|
|
SLAMF1
|
signaling lymphocytic activation molecule family member 1
|
|
SLAMF6
|
SLAM family member 6
|
|
SLAMF7
|
SLAM family member 7
|
|
SLAMF8
|
SLAM family member 8
|
|
SLAMF9
|
SLAM family member 9
|
|
SPEG
|
SPEG complex locus
|
|
TAPBP
|
TAP binding protein (tapasin)
|
|
TAPBPL
|
TAP binding protein-like
|
|
TARM1
|
T cell-interacting, activating receptor on myeloid cells 1
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TIE1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
|
|
TIGIT
|
T cell immunoreceptor with Ig and ITIM domains
|
|
TIMD4
|
T-cell immunoglobulin and mucin domain containing 4
|
|
TMEM25
|
transmembrane protein 25
|
|
TMEM81
|
transmembrane protein 81
|
|
TMIGD1
|
transmembrane and immunoglobulin domain containing 1
|
|
TMIGD2
|
transmembrane and immunoglobulin domain containing 2
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TREM2
|
triggering receptor expressed on myeloid cells 2
|
|
TREML1
|
triggering receptor expressed on myeloid cells-like 1
|
|
TREML2
|
triggering receptor expressed on myeloid cells-like 2
|
|
TREML4
|
triggering receptor expressed on myeloid cells-like 4
|
|
TRIO
|
trio Rho guanine nucleotide exchange factor
|
|
TTN
|
titin
|
|
TYRO3
|
TYRO3 protein tyrosine kinase
|
|
UNC5A
|
unc-5 homolog A (C. elegans)
|
|
UNC5B
|
unc-5 homolog B (C. elegans)
|
|
UNC5C
|
unc-5 homolog C (C. elegans)
|
|
UNC5D
|
unc-5 homolog D (C. elegans)
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCAN
|
versican
|
|
VPREB1
|
pre-B lymphocyte 1
|
|
VPREB3
|
pre-B lymphocyte 3
|
|
VSIG1
|
V-set and immunoglobulin domain containing 1
|
|
VSIG10
|
V-set and immunoglobulin domain containing 10
|
|
VSIG10L
|
V-set and immunoglobulin domain containing 10 like
|
|
VSIG2
|
V-set and immunoglobulin domain containing 2
|
|
VSIG4
|
V-set and immunoglobulin domain containing 4
|
|
VSIG8
|
V-set and immunoglobulin domain containing 8
|
|
VSTM1
|
V-set and transmembrane domain containing 1
|
|
VSTM2A
|
V-set and transmembrane domain containing 2A
|
|
VSTM2B
|
V-set and transmembrane domain containing 2B
|
|
VSTM2L
|
V-set and transmembrane domain containing 2 like
|
|
VSTM4
|
V-set and transmembrane domain containing 4
|
|
VSTM5
|
V-set and transmembrane domain containing 5
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
|
WFIKKN1
|
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1
|
|
WFIKKN2
|
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2
|
|
ZPBP
|
zona pellucida binding protein
|
|
ZPBP2
|
zona pellucida binding protein 2
|
